central retinal vein occlusions
Conditions
Brief summary
Change in visual acuity (BCVA on ETDRS scale) in letters read and validated between the start of treatment and 1 year.
Detailed description
Macular edema will be determined by the ophthalmologist from the OCT examination, Measurement of macular thickness in μm is performed using OCT-integrated measurement software, CRVO complications will be collected at one year from the patient's record, The number of aflibercept injections during the first year of follow-up will be collected at one year from the patient's record, The time between the last 2 injections of aflibercept will be collected at one year from the patient's file
Interventions
Sponsors
Fondation A De Rothschild, Fondation A De Rothschild, Fondation A De Rothschild
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in visual acuity (BCVA on ETDRS scale) in letters read and validated between the start of treatment and 1 year. | — |
Secondary
| Measure | Time frame |
|---|---|
| Macular edema will be determined by the ophthalmologist from the OCT examination, Measurement of macular thickness in μm is performed using OCT-integrated measurement software, CRVO complications will be collected at one year from the patient's record, The number of aflibercept injections during the first year of follow-up will be collected at one year from the patient's record, The time between the last 2 injections of aflibercept will be collected at one year from the patient's file | — |
Countries
France
Outcome results
None listed